Aprocitentan in resistant hypertension

Aprocitentan in resistant hypertension Since the 1960s, modern studies of hypertension and the availability of antihypertensive drugs have significantly improved blood pressure control. However, it has reached a plateau in high-income countries in the past decade. Many patients who have uncontrolled BP despite three antihypertensive treatments at optimal dose and from

Predicting cardiovascular disease with body mass index

Predicting cardiovascular disease with Body Mass Index BMI and CVD: An Introduction Obesity, as indexed by the high body mass index (BMI), is a major risk factor for cardiovascular disease (CVD). About 60 - 80% of patients with CVD are overweight. However, there are mixed findings on the effect of decreasing BMI

Hypertension Screening for Cardiovascular Health

Hypertension Screening for Cardiovascular Health Introduction Hypertension is a contributing risk factor for cardiovascular health. In the recent European Society of Cardiology (ESC) guidelines, the main recommendation for antihypertensive treatment of patients was regarded by the future risk of cardiovascular (CV) mortality, CV disease, or total mortality. The guideline state that the

Dental Screening for Cardiovascular Disease Risk

Dental Screening for Cardiovascular Disease Risk Introduction Periodontal disease (PD) is one of the most prevalent multifactorial chronic infections, affecting 46% of US adults. Though PD occurs in the 30-40 year age range, the incidence peaks at age 38 years. Atherosclerotic cardiovascular diseases (ACVD) is caused by heredity, environment, and their interactions; conventional

Blood pressure and CVD risk reduction

Blood pressure and CVD risk reduction Cardiovascular disease (CVD) is the primary cause of death worldwide, and in underdeveloped countries such as Haiti. It’s also found that among cardiovascular problems, hypertension is the leading risk factor. In this study, the researcher’s goal was to identify gaps in the hypertension continuum of

Community Hypertension and Atherosclerosis Risk

Community Hypertension and Atherosclerosis Risk Elevated blood pressure (BP) is considered one of the key risk factors in deaths caused by cardiovascular and renal problems. Despite the increase in awareness about hypertension and the advancements in treatment through the last decades, many patients still suffer from elevated BP while on treatment.

Cardiac Effects and Risks Among Thyroid Cancer Patients

Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. Cardiac Effects and Risks Among Thyroid Cancer Patients There are various types of thyroid cancer. They may not show initial symptoms and grow gradually. Other types develop aggressively and may

Can Sotagliflozin Prevent Cardiovascular Ailments for Patients with Diabetes and Chronic Kidney Disease?

Can Sotagliflozin Prevent Cardiovascular Ailments for Patients with Diabetes and Chronic Kidney Disease Cardiovascular diseases, including stroke, are major healthcare issues affecting humans worldwide. Between 2010 and 2030, the estimated total medical costs might escalate to from $273–$818 billion in the United States alone. Modifiable risk factors for stroke include hypertension, diabetes,

Aprocitentan in resistant hypertension